- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01990183
CareToy - A Modular Smart System for Infants' Rehabilitation at Home Based on Mechatronic Toys (CareToy)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study population will be made up of premature infants recruited at the local Department of Neonatology. The eligibility of infants, i.e. children who meet the criteria for inclusion and exclusion, will be evaluated by the Neonatology team. Recruitment should take place after discharge from Neonatal Intensive Care Unit (NICU) until the age stated by inclusion criteria and will begin with the signing of the participation agreement by the parents. During the recruitment extensive perinatal data will be collected from medical records. Each clinical centre will maintain these data in an internal database storing. Every child will be evaluated on the basis of a standard neurological examination supplemented by movement analysis on video recording using Prechtl's Method Qualitative Assessment of General Movements.
The sample will be randomized in two groups in order to compare the effectiveness of the CareToy intervention program vs standard care on motor, cognitive and visual development. We designed the study as randomized clinical trial. The sample size was calculated on the basis of the primary outcome measure (Infant Motor Profile [IMP], see Outcome measures).
Before the starting of the RCT we have planned a short pilot phase where few infants in order to assess the feasibility of the CareToy training and to tune and set-up the CareToy system and the rehabilitation packages. These cases will follow the same steps planned for the RCT.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- gestational age ≥ 28+0 weeks and 32+6 weeks
- corrected age at baseline: between 3 and 9 months;
- achievement of predefined cut off scores in gross motor ability derived from Ages & Stages Questionnaire® Third Edition (ASQ-3), in relation to corrected age (Bricker and Squires, 1999)
In detail:
- 4 months form (from 3 months to 4 months 30 days) score ≥ 10;
- 6 months form (from 5 months to 6 months 30 days) score ≥ 5 - < 50;
- 8 months form (from 7 months to 8 months 30 days) ≥ 10 - <30
Exclusion Criteria:
- infants with gestational age < 28 weeks or ≥ 33 weeks
- infants small for gestational age (i.e. weight below the 10th, ref)
- presence of brain damage (i.e. brain malformation, intra-ventricular haemorrhage [IVH] >1 ; any degree of periventricular leukomalacia (ref)
- known epilepsy or other form of seizure
- severe sensory deficits (blindness, deafness)
- other severe non neurological malformations
- participation in other experimental studies having rehabilitation aims
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: CareToy
CareToy intervention
|
Infants randomized in the Intervention Group will begin the habilitation intervention immediately after evaluation at baseline.
Rehabilitation staff, in accordance with each infant's needs and clinical characteristics, will set up the CareToy System to perform individualized intervention packages and its user's manual.
So a personalized CareToy System will be delivered at infant's home.
Moreover parents will attend a training course to use it.
During each daily home - session (about 30 - 45 minutes overall) it will be proposed to the child various interactive activities in supine, prone and sitting position.
The intervention phase lasts 4 weeks and each session will be remotely monitored by the rehabilitation staff.
|
|
OTHER: Standard Care
|
Current care advices in the management of preterm infants in the first months of life
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes on Infant Motor Profile (IMP)
Time Frame: T0(baseline, 1week before beginning of Study period);T1 (within 1 week after the end of the first training/control period; before the cross-over); T2 (within 1 week after the end of the second training/control 2nd period, after cross-over), T3: 18 months
|
IMP is a reliable video-based assessment of motor behaviour in infancy from 3 to 18 months.
It addresses to the child's motor abilities and evaluates motor behaviour in five domains: (1) variation, (2) variability (ability to select motor strategies), (3) movement fluency, (4) movement symmetry, and (5) motor performance.
It has been validated in preterm and full term infants.
This tool is intended to detect and quantify changes after intervention and it is reported as having a satisfactory intra and inter observer reliability and a very good concurrent validity with Alberta Infant Motor Scale and Touwen Infant Neurological Examination.
|
T0(baseline, 1week before beginning of Study period);T1 (within 1 week after the end of the first training/control period; before the cross-over); T2 (within 1 week after the end of the second training/control 2nd period, after cross-over), T3: 18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes on Alberta Infant Motor Scale (AIMS)
Time Frame: T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over) T3 (18 mths of corrected age)
|
This scale examines delayed and abnormal motor development in infants overtime and is valid for assessment from term until 18 months of age.
It has a good psychometric properties, it is quick to administer with limited handling and focuses on achievement of motor milestones, quality of posture and movement outcomes.
Sensitivity of AIMS items has been demonstrated in differentiate preterm's infant motor development, that typically results in lower scores, and full term infants motor development.
|
T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over) T3 (18 mths of corrected age)
|
|
CareToy for Clinics (CareToy C)
Time Frame: T0 (baseline, 1week before beginning of Study period);T1 (within 1 week after the end of the first training/control period; before the cross-over); T2 (within 1 week after the end of the second training/control 2nd period, after cross-over)
|
CareToy Evaluation Packages will be carried out using a highly equipped system, called Caretoy C in a subgroup of the enrolled infants.
This evaluation is mainly composed by visual packages designed to evaluate some different infants visual abilities i.e. attention, audio-visual, fixation shift and novelty.
|
T0 (baseline, 1week before beginning of Study period);T1 (within 1 week after the end of the first training/control period; before the cross-over); T2 (within 1 week after the end of the second training/control 2nd period, after cross-over)
|
|
Changes on Teller Acuity Cards
Time Frame: T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over) T3 (18 mths of corrected age)
|
Teller Acuity Cards II is a paediatric test used to evaluate visual acuity.
It is based on behavioural response by judging infant's attention to a series of cards showing stripes of different widths.
This tool allows rapid assessment of resolution (grating) visual acuity in infants, young children, and other populations where verbal response to recognition (letter) visual acuity charts is difficult or impossible.
It evaluates infants' acuity development and it has been used in several studies for diagnostic purposes and to measure results of early intervention.
|
T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over) T3 (18 mths of corrected age)
|
|
Changes on Bayley III - Cognitive subscale
Time Frame: T0 (baseline, 1week before beginning of Study period);T3: 18 months of Corrected Age (CA)
|
his scale is sensitive in detecting differences between normative sample and children at risk for delayed development, such as premature infants.
It has normative value referenced assessments, with means of 100 and Standard Deviation [SD] of 15 points.
Children whose scores are 2 SDs below the normative value in a domain are considered as having a significant delay in that domain.
Bayley---III is appropriate for administration to children between the ages of 1 month and 42 months (although norms extend downward to age 16 days).
The Bayley III revision includes Cognitive, Language, Motor, Social-Emotional, and Adaptive Behaviour scales.
Items on the cognitive subscale assess sensor-motor development, exploration, manipulation, object relatedness, concept formation, problem-solving and memory, all functions promoted during the CareToy sessions.
|
T0 (baseline, 1week before beginning of Study period);T3: 18 months of Corrected Age (CA)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ages & Stages Questionnaire (ASQ)
Time Frame: T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over); T3 (18 mths of corrected age)
|
It has been developed as a screening tool for developmental delay in infants in numerous paediatric populations with reported sensitivity, a measure of true positives, and specificity, a measure of true negatives, varying, with most studies reporting higher accuracy in at - risk populations. This questionnaire will be given to parents after enrolment in order to define the most appropriate starting time for each infant. |
T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over); T3 (18 mths of corrected age)
|
|
Social - Emotional Scale of BSID-III
Time Frame: T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over); T3 (18 mths of corrected age)
|
The survey uses this observational rating scale that provides a general indication of the infant's level of social- emotional development and information about whether or not sensory processing difficulties are present.
|
T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over); T3 (18 mths of corrected age)
|
|
Parenting Stress Index (PSI)
Time Frame: T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over) T3 (18 mths of corrected age)
|
This is a self-report questionnaire designed to identify specific parental, child, and situational characteristics most commonly associated with dysfunctional parenting.
Currently, the PSI is mostly used as a screening instrument for early identification of parent- child systems, which are under stress and at risk of developing dysfunctional parenting behaviour.
Validity of PSI is good and has been established in numerous studies on children with developmental problems, behaviour problems, disabilities and illnesses, as well as studies of at- risk families, and cross - cultural studies
|
T0 (baseline,1wk before beginning of Study period);T1(within 1 wk after end of 1st training/control period; before cross-over);T2 (within 1wk after end of 2nd training/control 2nd period, after cross-over) T3 (18 mths of corrected age)
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Rizzi R, Menici V, Cioni ML, Cecchi A, Barzacchi V, Beani E, Giampietri M, Cioni G, Sgandurra G; Clinical CareToy-R Consortium. Concurrent and predictive validity of the infant motor profile in infants at risk of neurodevelopmental disorders. BMC Pediatr. 2021 Feb 6;21(1):68. doi: 10.1186/s12887-021-02522-5.
- Sgandurra G, Beani E, Inguaggiato E, Lorentzen J, Nielsen JB, Cioni G. Effects on Parental Stress of Early Home-Based CareToy Intervention in Low-Risk Preterm Infants. Neural Plast. 2019 Jan 22;2019:7517351. doi: 10.1155/2019/7517351. eCollection 2019.
- Sgandurra G, Lorentzen J, Inguaggiato E, Bartalena L, Beani E, Cecchi F, Dario P, Giampietri M, Greisen G, Herskind A, Nielsen JB, Rossi G, Cioni G; CareToy Consortium. A randomized clinical trial in preterm infants on the effects of a home-based early intervention with the 'CareToy System'. PLoS One. 2017 Mar 22;12(3):e0173521. doi: 10.1371/journal.pone.0173521. eCollection 2017.
- Sgandurra G, Bartalena L, Cioni G, Greisen G, Herskind A, Inguaggiato E, Lorentzen J, Nielsen JB, Sicola E; CareToy Consortium. Home-based, early intervention with mechatronic toys for preterm infants at risk of neurodevelopmental disorders (CARETOY): a RCT protocol. BMC Pediatr. 2014 Oct 15;14:268. doi: 10.1186/1471-2431-14-268.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ICT-2011.5.1-287932
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterms at Risk for Developmental Disorders
-
University of Southern CaliforniaCompleted
-
Sebela Women's Health Inc.Syneos HealthActive, not recruitingWomen at Risk for PregnancyUnited States
-
Sebela Women's Health Inc.Synteract, Inc.CompletedWomen at Risk for PregnancyUnited States
-
Marit van de MheenVU University of Amsterdam; Netherlands Institute for the Study of Crime and...Active, not recruitingAt Risk for Criminal BehaviorNetherlands
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
Sebela Women's Health Inc.PRA Health SciencesNot yet recruitingContraception | Women at Risk for PregnancyUnited States
-
University of California, Los AngelesCompletedChildren at Risk for ASDUnited States
-
Boston Children's HospitalCompletedCar Seat Transition for At-risk InfantsUnited States
-
University of FloridaJohns Hopkins University; National Institutes of Health (NIH)CompletedYouths At-risk for Drug Use/AbuseUnited States
-
WestatChildren's Bureau - Administration for Children and FamiliesCompletedIn Foster Care | At Risk for Foster
Clinical Trials on CareToy
-
IRCCS Fondazione Stella MarisCompleted